Product Information

LISDEXAMFETAMINE 10 MG TB CHEW is a generic product labeled by SpecGx LLC, priced at $3.9122 per EA under NDC 00406512401. Its NADAC has been published 63 times since Sep 10, 2025.

FDA first approved this application on Dec 17, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LISDEXAMFETAMINE 10 MG TB CHEW

Lisdexamfetamine Dimesylate
$3.9122per EA
DEA Schedule CII

Strength

10 mg/1

Manufacturer

SpecGx LLC

NDC

00406512401

Classification

Generic

Dosage Form

TABLET, CHEWABLE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA218850

FDA Approved

12/17/2024

TE Code

AB

On Market Since

12/17/2024

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for LISDEXAMFETAMINE 10 MG TB CHEW has been published 63 times since Sep 10, 2025, and over the history we have for it it has declined 41.8%. The table below summarizes its recorded NADAC range and movement.

Current price$3.9122 per EA
All-time high$6.7173 (Sep 10, 2025)
All-time low$3.5865 (Aug 19, 2026)
52-week high$5.8791
52-week low$3.5865
Median price$5.3674
Average price$4.9299
Largest weekly change-12.4% (Jun 17, 2026)
Weeks tracked63
Tracking sinceSep 10, 2025

Price History

1W

+3.2%

1M

+4.7%

3M

+9.1%

6M

-8.6%

1Y

-33.5%

3Y

N/A

5Y

N/A

All

-41.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Lisdexamfetamine Dimesylate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LISDEXAMFETAMINE 10 MG TB CHEW?

The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 10 MG TB CHEW, manufactured by SpecGx LLC, is $3.9122 per EA (NDC 00406512401), effective Nov 18, 2026.

How has the price of LISDEXAMFETAMINE 10 MG TB CHEW changed over time?

Over the history we have for it, the NADAC for LISDEXAMFETAMINE 10 MG TB CHEW has declined 41.8%. It has been tracked across 63 weekly CMS publications since Sep 10, 2025.

What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 10 MG TB CHEW?

Since Sep 10, 2025, the NADAC for LISDEXAMFETAMINE 10 MG TB CHEW has ranged from a low of $3.5865 (Aug 19, 2026) to a high of $6.7173 (Sep 10, 2025), with a median of $5.3674 per EA.

Are there cheaper alternatives to LISDEXAMFETAMINE 10 MG TB CHEW?

No other NADAC-published product currently shares the active ingredient and strength of LISDEXAMFETAMINE 10 MG TB CHEW in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures LISDEXAMFETAMINE 10 MG TB CHEW?

LISDEXAMFETAMINE 10 MG TB CHEW (NDC 00406512401) is labeled by SpecGx LLC, and CMS classifies it as a generic product.